Clal Biotechnology reported ILS30.59M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 2.43B 963M Mar/2026
aTyr Pharma USD 359M 351M Nov/2026
Bio Path USD 1000K 0 Mar/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Cara Therapeutics USD 30M 336M Mar/2026
Clal Biotechnology ILS 52.36M 2.09M Mar/2025
Compugen USD 564.53M 41.47M Nov/2026
Immunic USD 64M 23M Dec/2025
RedHill Biopharma USD 8M 3M Jun/2026